{
    "Trade/Device Name(s)": [
        "OneTouch Verio IQ Blood Glucose Monitoring System",
        "OneTouch Verio Test Strips",
        "OneTouch Verio Control Solutions"
    ],
    "Submitter Information": "LifeScan Europe, a Division of Cilag GmbH International",
    "510(k) Number": "K110637",
    "Predicate Device Reference 510(k) Number(s)": [
        "K093745"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "August 19, 2011",
    "Summary Letter Received Date": "August 24, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Test strip"
    ],
    "Instrument(s)/Platform(s)": [
        "OneTouch Verio IQ Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection",
        "Electrochemical reaction"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solutions",
        "Alternative Site Testing Kit"
    ],
    "Document Summary": "FDA 510(k) summary for OneTouch Verio IQ Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips, forearm, or palm by single patient self-testing at home to monitor diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}